Geistlich Pharma AG (Geistlich) received advice from Baker McKenzie regarding the purchase of a minority interest in TRI Dental Implants Int. AG (TRI), a rapidly expanding supplier of digital implant systems. This strategic alliance demonstrates the organizations’ mutual dedication to developing digital dental solutions.